The QIMA story
At QIMA, we are on a mission to offer our clients smart solutions to make products you can trust.
Operating in over 100 countries, we serve the consumer products, food, and life sciences industries and help more than 30,000 brands, retailers, manufacturers, and growers achieve quality excellence.
We combine on-the-ground expertise with digital solutions that bring accuracy, transparency and intelligence for quality and compliance data.
What sets us apart is our unique culture. Our 5,000 Qimers live and make decisions every day by our QIMA Values. With client passion, integrity, and a commitment to making things simple, we disrupted the Testing, Inspection, and Certification industry. Are you ready to hop on this exciting ride with us and help us achieve our mission?
Our Life Sciences Division provides expert services in cellular and molecular pharmacology, dedicated to supporting the cosmetic and pharmaceutical industry with innovative research methods and bioanalysis. In addition to product evaluation and development services, we are committed to research into alternatives to animal experimentation and offer the industry a wide range of in vitro solutions to accelerate the global transition to cruelty-free practices in cosmetics and medicine.
As the Business Development Manager for our Pharmaceutical Division, you will play a pivotal role in driving the divisional revenue growth through the development and execution of strategic sales initiatives.
You will be responsible for developing and implementing sales strategies that align with the division's overall objectives, fostering a culture of success, and establishing strong relationships with key clients.
You will be directly reporting to the Life Sciences Director.
Key Responsibilities:
In order to succeed in this role, you have:
Qualifications:
Your main KPIs:
QIMA, founded in 1997 and headquartered in Buffalo, New York, is a quality control and compliance service provider that specializes in providing supply chain solutions to customers.
3 jobsSubscribe to Rise newsletter